Mayssa Attar

机构：University of California, Irvine, Bausch & Lomb (France)

发表论文 57 篇 · 总被引 1387 次 · h-index 15

代表论文

• Design and Conduct Considerations for First‐in‐Human Trials (2018 · Clinical and Translational Science · 被引 184)
• Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues (2018 · Journal of Ocular Pharmacology and Therapeutics · 被引 81)
• Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis (2023 · Toxins · 被引 39)
• Ocular emulsions and dry eye: a case study of a non-biological complex drug product delivered to a complex organ to treat a complex disease (2017 · Generics and Biosimilars Initiative Journal · 被引 19)
• Effect of Anti‐VEGF Therapy on the Disease Progression of Neovascular Age‐Related Macular Degeneration: A Systematic Review and Model‐Based Meta‐Analysis (2021 · The Journal of Clinical Pharmacology · 被引 18)
• Ocular Pharmacokinetics of Brimonidine Drug Delivery System in Monkeys and Translational Modeling for Selection of Dose and Frequency in Clinical Trials (2021 · Journal of Pharmacology and Experimental Therapeutics · 被引 16)